← back to search

Jianhua Fu

Jiangsu University · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal Cancer Research and Treatment, Esophageal and GI Pathology, Gastric Cancer Management and Outcomes, and Lung Cancer Diagnosis and Treatment.
h-index
41
citations
6,176
works
247
NIH funding
primary concept
email

Recent publications

Development and validation of a nomogram for predicting long-term survival in pN + esophageal squamous cell carcinoma treated using radical resection without neoadjuvant therapy.
2025cited by 0position: contributordoi
Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China
Thoracic Cancer 2024cited by 6position: middledoi
Changes in the recent three decades and survey on the current status of surgical treatment for esophageal cancer in China.
2024cited by 6position: contributordoi
A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)
EClinicalMedicine 2023cited by 46position: middledoi
CACA guidelines for holistic integrative management of esophageal carcinoma
Holistic Integrative Oncology 2023cited by 12position: middledoi
Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study
Journal of the National Cancer Center 2023cited by 10position: middledoi
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma
Clinical and Translational Medicine 2022cited by 85position: middledoi
Lymph Node Ratio Improves Prediction of Overall Survival in Esophageal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy: A National Cancer Database Analysis
Annals of Surgery 2022cited by 36position: middledoi
Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
EBioMedicine 2022cited by 36position: middledoi
Prognostic value of recurrence pattern in locally advanced esophageal squamous cell carcinoma: Results from the phase III trial NEOCRTEC5010
Journal of Thoracic and Cardiovascular Surgery 2022cited by 25position: middledoi
Efficacy and safety of esophagectomy via left thoracic approach versus via right thoracic approach for middle and lower thoracic esophageal cancer: a multicenter randomized clinical trial (NST1501)
Annals of Translational Medicine 2022cited by 8position: middledoi
Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
JAMA Surgery 2021cited by 339position: lastdoi
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
2021cited by 110position: contributordoi
Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
2021cited by 74position: contributordoi
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma
Annals of Translational Medicine 2021cited by 54position: middledoi
Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Annals of Surgery 2021cited by 48position: middledoi
Impact of Examined Lymph Node Count for Esophageal Squamous Cell Carcinoma in Patients who Underwent Right Transthoracic Esophagectomy.
2021cited by 19position: contributordoi
Prognostic Value of a Four-miRNA Signature in Patients With Lymph Node Positive Locoregional Esophageal Squamous Cell Carcinoma Undergoing Complete Surgical Resection.
2021cited by 17position: contributordoi
Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma
JAMA Network Open 2020cited by 181position: middledoi
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma
Radiotherapy and Oncology 2020cited by 130position: lastdoi
Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
2020cited by 128position: contributordoi
Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010
European Journal of Cancer 2020cited by 104position: middledoi
Recurrence patterns after neoadjuvant chemoradiotherapy compared with surgery alone in oesophageal squamous cell carcinoma: results from the multicenter phase III trial NEOCRTEC5010.
2020cited by 87position: contributordoi
A Recurrence Predictive Model for Thymic Tumors and Its Implication for Postoperative Management: a Chinese Alliance for Research in Thymomas Database Study.
2020cited by 40position: contributordoi
International consensus statement on robot-assisted minimally invasive esophagectomy (RAMIE)
Journal of Thoracic Disease 2020cited by 26position: middledoi
[Epidemiological characteristic and current status of surgical treatment for esophageal cancer by analysis of national registry database].
PubMed 2020cited by 25position: middledoi
The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis
Journal of Translational Medicine 2020cited by 12position: middledoi
Prophylactic thoracic duct ligation is associated with poor prognosis and regional lymph node relapse in esophageal squamous cell carcinoma.
2020cited by 12position: contributordoi
The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
2020cited by 7position: contributordoi
Impact of examined lymph node count for oesophageal squamous cell carcinoma in patients who underwent left transthoracic oesophagectomy.
2020cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Hong Yang · Kunming Medical University15 papers (2013–2023)Jing Wen · Jiangsu University12 papers (2013–2022)Wentao Fang · Henan Cancer Hospital9 papers (2016–2024)Qianwen Liu · Chongqing University of Posts and Telecommunications7 papers (2013–2023)Kongjia Luo · Sun Yat-sen University6 papers (2016–2022)Ke‐Neng Chen · Peking University5 papers (2015–2024)Zhentao Yu · Southwest University of Science and Technology4 papers (2016–2021)Chengchu Zhu · Wenzhou Medical University4 papers (2016–2022)Xiuying Xie · Sun Yat-sen University4 papers (2016–2022)Zhentao Yu · Sun Yat-sen University Cancer Center4 papers (2015–2024)Hui Liu · Sun Yat-sen University4 papers (2017–2021)Yongtao Han · University of Electronic Science and Technology of China3 papers (2016–2024)Yi Hu · Huanggang Normal University3 papers (2016–2018)Liewen Pang · Fudan University3 papers (2015–2019)Weimin Mao · Zhejiang University3 papers (2020–2022)Mian Xi · Union Hospital3 papers (2020–2023)Mengzhong Liu · State Key Laboratory of Oncology in South China3 papers (2020–2023)Yihong Ling · Sun Yat-sen University3 papers (2018–2022)Yun Wang · Sun Yat-sen University Cancer Center3 papers (2016–2020)Yuping Chen · Nanjing University of Finance and Economics3 papers (2016–2021)